Market Overview:
The global animal pharmaceutical market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for animal-derived products, rising awareness about zoonotic diseases, and growing companion animal population. The vaccine segment is expected to dominate the market during the forecast period owing to rising demand for preventive healthcare measures among animals. Asia Pacific is projected to be the fastest-growing region in terms of revenue during the forecast period.
Product Definition:
A pharmaceutical product that is used to treat or prevent disease in animals. Animal pharmaceuticals are important because they help keep animals healthy and can help reduce the spread of diseases.
Vaccine:
Vaccine is a preparation used to stimulate the body's immune system to produce antibodies against an infectious disease. The vaccine can be of two types, active and passive. In an active vaccine, the disease agent is introduced into the body in order to create an antibody response. In contrast, in a passive vaccine, material from the disease agent is used to create antibodies that are already present within the body.
Veterinary Drugs:
Veterinary drugs are the medications used to treat diseases in animals. They are distinct from human pharmaceuticals in their chemical composition and different applications. The global animal pharmaceutical market is expected to grow at a lucrative rate during the forecast period owing to increasing demand for animal-derived food products, growth of companion & livestock animals, rising awareness among pet owners regarding health & well-being of their pets and increased expenditure on veterinary healthcare by owners.
Application Insights:
The companion animal segment held the largest share of more than 60.0% in 2017. The growth can be attributed to the growing importance of pets in several countries, such as U.S., China, India and Australia among others. Moreover, increasing spending on pet healthcare is expected to drive demand for animal pharmaceuticals over the forecast period.
Regional Analysis:
North America dominated the global animal pharmaceutical market in 2017. The region is expected to maintain its position during the forecast period due to presence of a large number of companies and high R&D expenditure by these companies. Moreover, increasing demand for meat and dairy products is also one of the major factors responsible for driving growth in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income coupled with growing population especially in China & India which are major markets for veterinary medicines and vaccines respectively. This has led to an increase in demand for companion animals as well as food animals, thereby boosting industry expansion across this region particularly since most developed countries have been experiencing a decline or stagnant growth rate with respect rising pet ownership but still continue their exports mainly from China & India thus propelling regional market development over next eight years (28).
Growth Factors:
- Increasing demand for meat and dairy products, especially in developing countries.
- Rising awareness about animal health and the benefits of preventive care.
- Growing demand for pharmaceuticals as a result of increasing pet ownership rates around the world.
- Advances in veterinary medicine and diagnostics that improve treatment outcomes and increase efficiency in disease diagnosis and treatment planning 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Animal Pharmaceutical Market Research Report
By Type
Vaccine, Veterinary Drugs, Other
By Application
Companion Animal, Poultry, Other
By Companies
Zoetis, Merck, Merial, Elanco, Bayer Animal Health, Boehringer Ingelheim Vetmedica, Virbac, Ceva Sante Animale, Vétoquinol, Jurox, MSD Animal Health Australia, PARNELL, CAHIC, Ringpu Biology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
171
Number of Tables & Figures
120
Customization Available
Yes, the report can be customized as per your need.
Global Animal Pharmaceutical Market Report Segments:
The global Animal Pharmaceutical market is segmented on the basis of:
Types
Vaccine, Veterinary Drugs, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Companion Animal, Poultry, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zoetis
- Merck
- Merial
- Elanco
- Bayer Animal Health
- Boehringer Ingelheim Vetmedica
- Virbac
- Ceva Sante Animale
- Vétoquinol
- Jurox
- MSD Animal Health Australia
- PARNELL
- CAHIC
- Ringpu Biology
Highlights of The Animal Pharmaceutical Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Vaccine
- Veterinary Drugs
- Other
- By Application:
- Companion Animal
- Poultry
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Animal Pharmaceutical Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Animal pharmaceuticals are medications that are created specifically for use in animals. They may be used to treat a variety of conditions, including cancer, heart disease, and other diseases.
Some of the key players operating in the animal pharmaceutical market are Zoetis, Merck, Merial, Elanco, Bayer Animal Health, Boehringer Ingelheim Vetmedica, Virbac, Ceva Sante Animale, V©toquinol, Jurox, MSD Animal Health Australia, PARNELL, CAHIC, Ringpu Biology.
The animal pharmaceutical market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Animal Pharmaceutical Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Animal Pharmaceutical Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Animal Pharmaceutical Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Animal Pharmaceutical Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Animal Pharmaceutical Market Size & Forecast, 2020-2028 4.5.1 Animal Pharmaceutical Market Size and Y-o-Y Growth 4.5.2 Animal Pharmaceutical Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Vaccine
5.2.2 Veterinary Drugs
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Companion Animal
6.2.2 Poultry
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Animal Pharmaceutical Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Animal Pharmaceutical Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Vaccine
9.6.2 Veterinary Drugs
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Companion Animal
9.10.2 Poultry
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Vaccine
10.6.2 Veterinary Drugs
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Companion Animal
10.10.2 Poultry
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Vaccine
11.6.2 Veterinary Drugs
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Companion Animal
11.10.2 Poultry
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Vaccine
12.6.2 Veterinary Drugs
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Companion Animal
12.10.2 Poultry
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Vaccine
13.6.2 Veterinary Drugs
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Companion Animal
13.10.2 Poultry
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Animal Pharmaceutical Market: Competitive Dashboard
14.2 Global Animal Pharmaceutical Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Zoetis
14.3.2 Merck
14.3.3 Merial
14.3.4 Elanco
14.3.5 Bayer Animal Health
14.3.6 Boehringer Ingelheim Vetmedica
14.3.7 Virbac
14.3.8 Ceva Sante Animale
14.3.9 Vétoquinol
14.3.10 Jurox
14.3.11 MSD Animal Health Australia
14.3.12 PARNELL
14.3.13 CAHIC
14.3.14 Ringpu Biology